Stamulumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Stamulumab" in English language version.

refsWebsite

Global rank English rank

5web.archive.org

1^st place

1^st place

low place

low place

low place

low place

14^th place

14^th place

low place

low place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1fshsociety.org

low place

low place

193^rd place

152^nd place

5^th place

5^th place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

archive.today

Wyeth Analyzing MYO-029 Results Archived 2013-04-15 at archive.today, Muscular Dystrophy Association announcement, December 4, 2006
"Wyeth Won't Develop MYO-029 for MD". 11 March 2008. Archived from the original on 2012-09-06. Retrieved 2008-11-03.

clinicaltrials.gov

"Study Evaluating MYO-029 in Adult Muscular Dystrophy". clinicaltrials.gov. 24 June 2007. Retrieved 2023-02-19.

doi.org

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. (May 2008). "A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy". Annals of Neurology. 63 (5): 561–71. doi:10.1002/ana.21338. PMID 18335515. S2CID 9934165.

fshsociety.org

FSH Watch Newsletter Archived 2008-03-09 at the Wayback Machine, pg 11, FSH Society, Summer 2007

mda.org

Wyeth Analyzing MYO-029 Results Archived 2013-04-15 at archive.today, Muscular Dystrophy Association announcement, December 4, 2006
"Wyeth Won't Develop MYO-029 for MD". 11 March 2008. Archived from the original on 2012-09-06. Retrieved 2008-11-03.

mdausa.org

"Blocking Myostatin Proves Beneficial in Mice with DMD". MDA Research News. 27 November 2002. Archived from the original on 22 December 2002. Retrieved 2023-02-19.
"New Myostatin Blocker Makes Mouse Muscles 60 Percent Larger". MDA Research News. 6 January 2006. Archived from the original on 11 January 2006. Retrieved 2023-02-19.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. (May 2008). "A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy". Annals of Neurology. 63 (5): 561–71. doi:10.1002/ana.21338. PMID 18335515. S2CID 9934165.

semanticscholar.org

api.semanticscholar.org

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. (May 2008). "A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy". Annals of Neurology. 63 (5): 561–71. doi:10.1002/ana.21338. PMID 18335515. S2CID 9934165.

web.archive.org

Wyeth Product Pipeline Archived 2007-05-09 at the Wayback Machine, Wyeth, Website accessed April 22, 2007
"Wyeth Initiates Clinical Trial with Investigational Muscular Dystrophy Therapy MYO-029". www.medicalnewstoday.com (Press release). 28 February 2005. Archived from the original on 15 March 2005. Retrieved 2023-02-19.
"Blocking Myostatin Proves Beneficial in Mice with DMD". MDA Research News. 27 November 2002. Archived from the original on 22 December 2002. Retrieved 2023-02-19.
FSH Watch Newsletter Archived 2008-03-09 at the Wayback Machine, pg 11, FSH Society, Summer 2007
"New Myostatin Blocker Makes Mouse Muscles 60 Percent Larger". MDA Research News. 6 January 2006. Archived from the original on 11 January 2006. Retrieved 2023-02-19.

wired.com

Madrigal, Alexis (24 January 2008). "Pharma Company Responds to WiSci on Muscle-Building Drug". Wired. ISSN 1059-1028. Retrieved 2023-02-19.

worldcat.org

search.worldcat.org

Madrigal, Alexis (24 January 2008). "Pharma Company Responds to WiSci on Muscle-Building Drug". Wired. ISSN 1059-1028. Retrieved 2023-02-19.

wyeth.com

Wyeth Product Pipeline Archived 2007-05-09 at the Wayback Machine, Wyeth, Website accessed April 22, 2007